D. J. Moore, A. B. West, V. L. Dawson, D. , T. M. Duke et al., MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE, Annual Review of Neuroscience, vol.28, issue.1, pp.57-87, 2005.
DOI : 10.1146/annurev.neuro.28.061604.135718

K. Graeber, M. B. Simunovic, F. Yi, M. Wang, Y. Macey et al., Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease Gene expression profiling of substantia nigra dopamine neurons: Further insights into Parkinson's disease pathology Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Ann. N.Y, pp.1-11, 2005.

. S. Acad, M. Basso, S. Giraudo, D. Corpillo, B. Bergamasco et al., Proteome analysis of human substantia nigra in Parkinson's disease Identification of proteins in human substantia nigra Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease Nonhuman primate models of Parkinson's disease A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4 macaque model of Parkinson's disease Complications of CTguided stereotactic biopsy of intra-axial brain lesions, Proteomics: Clin. Appl. 2, 776?782. (8) Licker, ILAR J. 48, 339?355. (10), pp.4656-4667, 1053.

C. Arce, J. J. Garrido, M. G. Spillantini, M. L. Schmidt, V. M. Lee et al., Alpha-synuclein in Lewy bodies Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism UCHL1 is a Parkinson's disease susceptibility gene Association of a monoamine oxidase B allele with Parkinson's disease Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: An in situ hybridization study The basal ganglia. Trends Neurosci DARPP-32: Regulator of the efficacy of dopaminergic neurotransmission, Biological pathway analysis by ArrayUnlock and Ingenuity Pathway Analysis. BMC Proc. 3 256?259. (16) 245?253. (21) 60?62. (22) Fienberg, pp.512-521, 1988.

|. Acs-chemical-neuroscience-research-article, . Acs-chem, H. C. Neurosci-hemmings, . Jr, A. C. Nairn et al., DARPP-32, a dopamine-and adenosine 3?:5?- monophosphate-regulated phosphoprotein enriched in dopamineinnervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus Regional and cellular gene expression changes in human Huntington's disease brain Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease, 99?110. (25), pp.385-392, 1021.

J. Silburn, P. A. Mackay-sim, A. Wells, C. A. Mellick, G. D. Bossers et al., A cross-study transcriptional analysis of Parkinson's disease Analysis of gene expression in Parkinson's disease: Possible involvement of neurotrophic support and axon guidance in dopaminergic cell death, PLoS One Brain Pathol, vol.4, issue.19, pp.91-107, 2009.

J. Palaniappan, C. Federoff, H. J. Imbeaud, S. Graudens, E. Boulanger et al., DNA microarrays: Translation of the genome from laboratory to clinic Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces Deep brain stimulation for Parkinson's disease Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease EthoVision: A versatile video tracking system for automation of behavioral experiments, substantia nigra and striatum in Parkinson's disease, pp.275-282, 2000.